Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2009

01-11-2009

Pulmonary embolism and portal vein thrombosis in an immunocompetent adolescent with acute cytomegalovirus hepatitis

Authors: Antonio Mendoza Ladd, Rakesh Goyal, Louis Rosainz, Peter Baiocco, Larry DiFabrizio

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2009

Login to get access

Abstract

Cytomegalovirus infection is usually asymptomatic or resembles infectious mononucleosis with fever, pharyngitis, arthralgias, lymphadenopathy, and atypical lymphocytosis. Even though primary CMV infection is usually self-limited in healthy individuals, significant complications can develop in immunocompromised patients. Venous or arterial thromboembolic phenomena are uncommon, yet very serious complications of CMV infection. Most published reports describe immunosupressed patients after organ transplantation or in the presence of HIV co-infection. However, thrombotic events in CMV infected immunocompetent individuals may occur. We describe the case of an immunocompetent adolescent with acute cytomegalovirus hepatitis that was complicated with pulmonary embolism and portal vein thrombosis. To our knowledge, this is the first reported case in which these two thrombotic phenomena occurred simultaneously in an adolescent with no obvious predisposing factors for thrombosis in the setting of an acute CMV infection.
Literature
2.
go back to reference Zhou YF, Yu ZX, Wanishsawad C et al (1999) The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation and expression of PDGF beta-receptor. Biochem Biophys Res Commun 256:608–613. doi:10.1006/bbrc.1999.0387 CrossRefPubMed Zhou YF, Yu ZX, Wanishsawad C et al (1999) The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation and expression of PDGF beta-receptor. Biochem Biophys Res Commun 256:608–613. doi:10.​1006/​bbrc.​1999.​0387 CrossRefPubMed
3.
go back to reference van Dam-Mieras MCE, Muller AD, van Hinsbergh VWM et al (1992) The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 68(3):364–370PubMed van Dam-Mieras MCE, Muller AD, van Hinsbergh VWM et al (1992) The procoagulant response of cytomegalovirus infected endothelial cells. Thromb Haemost 68(3):364–370PubMed
7.
go back to reference Schambeck CM, Hinney K, Gieixner J et al (2000) Venous thromboembolism and associated high plasma factor VIII levels: linked to cytomegalovirus infection? Throm Haemost 83:510–511 Schambeck CM, Hinney K, Gieixner J et al (2000) Venous thromboembolism and associated high plasma factor VIII levels: linked to cytomegalovirus infection? Throm Haemost 83:510–511
8.
go back to reference Nieto FJ, Sorlie P, Cornstock GW et al (1997) Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link? Arterioscler Thromb Vasc Biol 17:1780–1785PubMed Nieto FJ, Sorlie P, Cornstock GW et al (1997) Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link? Arterioscler Thromb Vasc Biol 17:1780–1785PubMed
9.
go back to reference Squizzato A, Ageno W, Cattaneo A et al (2007) A case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 44:13–16. doi:10.1086/509641 CrossRef Squizzato A, Ageno W, Cattaneo A et al (2007) A case report and literature review of portal vein thrombosis associated with cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 44:13–16. doi:10.​1086/​509641 CrossRef
10.
go back to reference Abgueguen P, Delbos V, Chennebault JM et al (2003) Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review. Clin Infect Dis 36:e134–e139. doi:10.1086/374664 CrossRefPubMed Abgueguen P, Delbos V, Chennebault JM et al (2003) Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review. Clin Infect Dis 36:e134–e139. doi:10.​1086/​374664 CrossRefPubMed
13.
go back to reference Labarca JA, Rabaggliati RM, Radrgan FJ et al (1997) Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis 24:197–200PubMed Labarca JA, Rabaggliati RM, Radrgan FJ et al (1997) Antiphospholipid syndrome associated with cytomegalovirus infection: case report and review. Clin Infect Dis 24:197–200PubMed
19.
go back to reference Gueddi S, Righini M, Mezger N et al (2006) Portal vein thrombosis following a primary cytomegalovirus infection in an immunocompetent adult. Thromb Haemost 95:199–201PubMed Gueddi S, Righini M, Mezger N et al (2006) Portal vein thrombosis following a primary cytomegalovirus infection in an immunocompetent adult. Thromb Haemost 95:199–201PubMed
21.
go back to reference Chelbi F, Boutin-Le Thi Huong D, Frigui M et al (2006) Portal thrombosis complicating an acute cytomegalovirus infection in an immunocompetent patient. La revue de medicine interne 27:54–58CrossRef Chelbi F, Boutin-Le Thi Huong D, Frigui M et al (2006) Portal thrombosis complicating an acute cytomegalovirus infection in an immunocompetent patient. La revue de medicine interne 27:54–58CrossRef
22.
go back to reference Estival JL, Debourdeau P, Zammit C et al (2001) Spontaneous portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent patient. Presse Med 30:1876–1878PubMed Estival JL, Debourdeau P, Zammit C et al (2001) Spontaneous portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent patient. Presse Med 30:1876–1878PubMed
24.
27.
go back to reference Primignani M, Martinelli I, Bucciarelli P et al (2005) Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 41(3):603–608CrossRefPubMed Primignani M, Martinelli I, Bucciarelli P et al (2005) Risk factors for thrombophilia in extrahepatic portal vein obstruction. Hepatology 41(3):603–608CrossRefPubMed
28.
go back to reference Shah S, DasGupta A, Sharma A et al (2005) Thrombophilic conditions in non-cirrhotic portal vein thrombosis. Indian J Gastroenterol 24:205–210PubMed Shah S, DasGupta A, Sharma A et al (2005) Thrombophilic conditions in non-cirrhotic portal vein thrombosis. Indian J Gastroenterol 24:205–210PubMed
29.
Metadata
Title
Pulmonary embolism and portal vein thrombosis in an immunocompetent adolescent with acute cytomegalovirus hepatitis
Authors
Antonio Mendoza Ladd
Rakesh Goyal
Louis Rosainz
Peter Baiocco
Larry DiFabrizio
Publication date
01-11-2009
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2009
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-008-0303-1

Other articles of this Issue 4/2009

Journal of Thrombosis and Thrombolysis 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine